Why Avantor Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday’s Mid-Day Session - Avantor (NYSE:AVTR), Business First Bancshares (NASDAQ:BFST)

Gainers

Losers

Now Read This: Bitcoin Falls; Synthetix, Pepe Among Top Losers

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

Gainers

Unique Fabricating, Inc. (NYSE:UFAB) shares jumped 113% to $0.4605 after gaining 12% on Thursday.
Reata Pharmaceuticals, Inc. (NASDAQ:RETA) gained 53.3% to $166.41 after Biogen agreed to acquire the company.
Bluejay Diagnostics, Inc. (NASDAQ:BJDX) shares gained 48.5% to $7.95.
AEye, Inc. (NASDAQ:LIDR) shares climbed 48.5% to $0.3300 after falling around 4% on Thursday.
View, Inc. (NASDAQ:VIEW) gained 40.4% to $15.45.
Infobird Co., Ltd (NASDAQ:IFBD) gained 40% to $1.17.
Business First Bancshares, Inc. (NASDAQ:BFST) rose 28% to $21.77 following upbeat quarterly results.
Gracell Biotechnologies Inc. (NASDAQ:GRCL) climbed 24.3% to $3.9898.
INVO Bioscience, Inc. (NASDAQ:INVO) gained 23% to $4.6189. INVO BioScience recently announced 1-for-20 reverse stock split.
Mersana Therapeutics, Inc. (NASDAQ:MRSN) gained 22% to $1.3115. Mersana Therapeutics said that the UPLIFT clinical trial of upifitamab rilsodotin did not meet its primary endpoint.
Roku, Inc. (NASDAQ:ROKU) jumped 20.8% to $82.43 after the company reported better-than-expected second-quarter results and issued strong third-quarter guidance.
Larimar Therapeutics, Inc. (NASDAQ:LRMR) rose 20.5% to $3.75.
Homology Medicines, Inc. (NASDAQ:FIXX) shares climbed 19.7% to $1.1250. Homology Medicines announced initial data from the first dose cohort in the pheEDIT Phase 1 dose-escalation trial evaluating gene editing candidate HMI-103 in adults with classical phenylketonuria (PKU). Homology will not be further developing its programs and will be instituting a related reduction in force while it explores options for the company and its assets, including HMI-103. The company is reducing its workforce by 87% and stopping further program development efforts outside of required actions, including continued collection of data from and monitoring of participants in its clinical trials.
Huron Consulting Group Inc. (NASDAQ:HURN) gained 18.5% to $94.00 following upbeat quarterly results.
TAL Education Group (NYSE:TAL) climbed 18.1% to $7.57. TAL Education released quarterly results yesterday.
The Boston Beer Company, Inc. (NYSE:SAM) jumped 18.1% to $370.40 after the company yesterday reported better-than-expected quarterly results.
Costamare Inc. (NYSE:CMRE) rose 17.1% to $11.12 following strong quarterly sales.
Coursera, Inc. (NYSE:COUR) shares gained 16.3% to $15.13 following better-than-expected second-quarter sales results. Cantor Fitzgerald upgraded Coursera from Neutral to Overweight and raised the price target from $13 to $17.
Beazer Homes USA, Inc. (NYSE:BZH) jumped 16.2% to $32.28 following better-than-expected quarterly results.
Bilibili Inc. (NASDAQ:BILI) gained 15.4% to $18.70.
Inpixon (NASDAQ:INPX) shares rose 15.1% to $0.2325 after falling around 20% on Thursday. Inpixon recently agreed to merge with XTI Aircraft Company.
Celestica Inc. (NYSE:CLS) rose 14.8% to $20.69 after RBC Capital upgraded the stock from Sector Perform to Outperform and raised its price target from $14 to $22. TD Cowen also upgraded the stock from Hold to Buy and raised the price target from $14.5 to $23.
SIGA Technologies, Inc. (NASDAQ:SIGA) gained 14.7% to $5.84 after the company announced a $138 million U.S. government contract for oral and IV TPOXX treatment.
Silicon Motion Technology Corporation (NASDAQ:SIMO) rose 14.5% to $60.10 following strong quarterly sales.
SkyWest, Inc. (NASDAQ:SKYW) surged 13.4% to $44.96 following second-quarter results.
GDS Holdings Limited (NASDAQ:GDS) gained 13.4% to $13.59. Shares of Chinese stocks traded higher amid hopes of policy support and further stimulus measures.
Cardlytics, Inc. (NASDAQ:CDLX) rose 12.3% to $10.81.
T. Rowe Price Group, Inc. (NASDAQ:TROW) gained 10.5% to $129.47 after the company reported better-than-expected second-quarter financial results.
Meritage Homes Corporation (NYSE:MTH) gained 8.4% to $149.99 following quarterly results.
Skechers U.S.A., Inc. (NYSE:SKX) climbed 7.9% to $55.16 after the company reported better-than-expected second-quarter results.
Intel Corporation (NASDAQ:INTC) shares rose 5.3% to $36.40 after the company reported better-than-expected second-quarter results and issued strong guidance.

Losers

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) shares declined 39% to $1.0850. Tonix Pharmaceuticals priced public offering of 7 million common shares at $1 per share.
Sleep Number Corporation (NASDAQ:SNBR) fell 29.5% to $27.12 after the company reported mixed second-quarter results.
Femasys Inc. (NASDAQ:FEMY) shares fell 22.5% to $0.6510. Femasys shares jumped over 130% on Thursday after the company announced that the United States Patent and Trademark Office issued a Notice of Allowance for FemBloc for permanent birth control.
Eos Energy Enterprises, Inc. (NASDAQ:EOSE) fell 20.8% to $2.0950. Eos Energy Enterprises said it expects second-quarter revenue of $0.2 million.
Carmell Therapeutics Corporation (NASDAQ:CTCX) dropped 19.6% to $3.52. Carmell Therapeutics recently announced a merger with Axoloti Biologix.
Fresh Vine Wine, Inc. (NYSE:VINE) shares fell 19.1% to $0.51. Fresh Vine Wine said on July 14, Roger Cockroft's employment with and service as CEO of the company ended and Hitesh Dheri's employment with and service as CFO ended.
G Medical Innovations Holdings Ltd (NASDAQ:GMVD) declined 16% to $0.2899.
GSI Technology, Inc. (NASDAQ:GSIT) fell 15.1% to $4.21 after posting a first-quarter loss.
Gogo Inc. (NASDAQ:GOGO) fell 14.8% to $14.81.
Genelux Corporation (NASDAQ:GNLX) declined 14.8% to $19.90.
Mallinckrodt plc (NYSE:MNK) fell 13% to $1.41 after jumping over 28% on Thursday.
Sweetgreen, Inc. (NYSE:SG) fell 12.2% to $13.56 after the company reported worse-than-expected second-quarter results.
Enphase Energy, Inc. (NASDAQ:ENPH) shares fell 10.1% to $149.95 after the company posted downbeat second-quarter sales and issued weak sales guidance.
Avantor, Inc. (NYSE:AVTR) fell 9.9% to $20.57 after the company reported worse-than-expected second-quarter financial results.
MarineMax, Inc. (NYSE:HZO) declined 8.2% to $37.36. B. Riley downgraded MarineMax from Buy to Neutral and lowered the price target from $48 to $43.
PennyMac Mortgage Investment Trust (NYSE:PMT) fell 7.7% to $13.09 following weak quarterly results.
SolarEdge Technologies, Inc. (NASDAQ:SEDG) shares declined 5.4% to $228.77. Infineon and SolarEdge inked a multi-year capacity reservation supplier agreement to foster green energy solutions.
Ford Motor Company (NYSE:F) shares slipped 3.9% to $13.19. Ford reported upbeat earnings for its second quarter and raised its FY23 adjusted EBIT guidance.